Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate- stimulated noradrenaline and dopamine release in the brain

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 359, Issue 6, 1999, Pages 466-470

  Kathmann, M ^a   Bauer, U ^a   Schlicker, E ^a   Gothert M ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

3H SR 141716 binding; Cannabinoid CB1 receptors; Dopamine release; Guinea pig hippocampus; Kainate; NMDA; Noradrenaline release; Rat striatum

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; DOPAMINE; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID; NORADRENALIN; RIMONABANT; AMINO ACID RECEPTOR STIMULATING AGENT; CANNABINOID; CYCLOHEXANOL DERIVATIVE; DRUG RECEPTOR; MORPHOLINE DERIVATIVE; N METHYLASPARTIC ACID; NAPHTHALENE DERIVATIVE; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; DRUG RECEPTOR BINDING; GUINEA PIG; HIPPOCAMPUS; MALE; NONHUMAN; NORADRENALIN RELEASE; RAT; RECEPTOR AFFINITY; ANIMAL; BINDING COMPETITION; BRAIN CORTEX; BRAIN LEVEL; MEMBRANE; METABOLISM; STIMULATION; WISTAR RAT;

ANIMALS; BINDING, COMPETITIVE; BRAIN CHEMISTRY; CANNABINOIDS; CEREBRAL CORTEX; CYCLOHEXANOLS; DOPAMINE; EXCITATORY AMINO ACID AGONISTS; GUINEA PIGS; KAINIC ACID; MALE; MEMBRANES; MORPHOLINES; N-METHYLASPARTATE; NAPHTHALENES; NOREPINEPHRINE; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; STIMULATION, CHEMICAL;

EID: 0032587160     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005377     Document Type: Article

References (16)

1. Bliss TVP, Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31-39
2. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
3. Cadogan AK, Alexander SPH, Boyd EA, Kendall DA (1997) Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum. J Neurochem 69:1131-1137
4. Childers SR, Breivogel CS (1998) Cannabis and endogenous cannabinoid systems. Drug Alcohol Depend 51:173-187
5. Fink K, Schultheiß R, Göthert M (1992) Stimulation of noradrenaline release in human cerebral cortex mediated by N-methyl-D-aspartate (NMDA) and non-NMDA receptors. Br J Pharmacol 106:67-72
6. Krebs MO, Desce JM, Kemel ML, Gauchy C, Godeheu G, Cheramy A, Glowinski J (1991) Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J Neurochem 56:81-85
7. 2 receptors. Br J Pharmacol 124:619-622
8. 2+ currents by reversal of tonic CB1 cannabinoid receptor activity. Mol Pharmacol 54:1064-1072
9. 2 receptors. Pharmacol Ther 74:129-180
10. Pittaluga A, Raiteri M (1992) N-Methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization. J Pharmacol Exp Ther 260:232-237
11. Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Néliat G, Caput D, Ferrara P, Soubrié P, Brelière JC, Le Fur G (1994) SR141716, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244
12. 3H]-SR 141716 A, a selective brain (CB1) cannabinoid receptor antagonist in rodent brain. Life Sci 58:1239-1247
13. Rinaldi-Carmona M, Barth F, Millan J, Derocq JM, Casellas P, Congy C, Oustric D, Sarran M, Bouaboula M, Calandra B, Portier M, Shire D, Brelière JC, Le Fur G (1998) SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J Pharmacol Exp Ther 284:644-650
14. 2-autoreceptor and presynaptic inhibitory heteroreceptors on noradrenergic neurones. Brain Res Bull 47:129-132
15. Schlicker E, Timm J, Zentner J, Göthert M (1997) Cannabinoid receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus. Naunyn-Schmiedeberg's Arch Pharmacol 356:583-589
16. Terranova JP, Michaud JC, Le Fur G, Soubrié P (1995) Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716A, a selective antagonist of CB1 cannabinoid receptors. Naunyn-Schmiedeberg's Arch Pharmacol 352:576-579